Expression And Purification Of Human DNA Topoisomerase I In Pichia Yeast Expression System | 17290
ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

6th International Conference on Vaccines and Immunology

Geneva, Switzerland

3rd European Congress on Virology

Geneva, Switzerland
Google Scholar citation report
Citations : 1600

Journal of Biotechnology & Biomaterials received 1600 citations as per Google Scholar report

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Access to Global Online Research in Agriculture (AGORA)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Expression and purification of human DNA topoisomerase I in pichia yeast expression system

5th World Congress on Biotechnology

Mooi Kwai Chan

Accepted Abstracts: J Biotechnol Biomater

DOI: 10.4172/2155-952X.S1.029

Human DNA Topoisomerase I (Topo I) plays an important role in the transcription and replication processes. The enzyme can relax negative and positive supercoil DNA by introducing a transient nick on the single stranded DNA, rotation of the free stranded DNA and religation of the broken strand. As the enzyme has been used as the targets of anticancer drugs for chemotherapy, the enzyme can be developed as a molecular target for screening of potential anticancer compounds. Therefore, producing an in house Topo I through recombinant technology will facilitate our project in screening of anticancer compounds. In this study, the coding region of Top I from cDNA of MDA-MB 231 cell was amplified by PCR with Phusion enzyme. The cDNA which is 2298bp in length was ligated into a yeast expression vector, pPICZA-alpha and transformed into Top?10 electrocompetent cells. The positive clones with the desired insert were isolated and plasmid was purified for sequencing. The recombinant plasmid was linearized with Sac I restriction enzyme and transformed into pichia strain, GS 115 by electroporation. The positive integrated transformants was grown in BMGY(Buffered Glycerol-complex medium)and expression of the protein was induced in BMMY (Buffered Methanol-complex medium), pH 6.0 at 28 0 C, 250 rpm with addition of 0.5% (V/V) methanol every 24 hour. Activity of the recombinant enzyme was determined with DNA relaxation assay using 1 μl of the culture supernatant. The enzyme was purified with HiTrap CM FF weak cation exchanger column (GE healthcare, Sweden) using ?KTAprime plus protein purification system. SDS-PAGE and Western blot analyses showed the recombinant human Topo I with a molecular weight apparently of 85 kDa which is approximately 10 kDA less than the actual molecular weight of human Topo I. This might due to the proteolysis of the protein during the extracellular expression.